These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 16898223)

  • 1. Chemokines and their receptors in islet allograft rejection and as targets for tolerance induction.
    Merani S; Truong WW; Hancock W; Anderson CC; Shapiro AM
    Cell Transplant; 2006; 15(4):295-309. PubMed ID: 16898223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokines and Their Receptors in Islet Allograft Rejection and as Targets for Tolerance Induction.
    Merani S; Truong WW; Hancock W; Anderson CC; Shapiro AMJ
    Cell Transplant; 2006 Apr; 15(4):295-309. PubMed ID: 28863747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokines in islet allograft rejection.
    Abdi R; Means TK; Luster AD
    Diabetes Metab Res Rev; 2003; 19(3):186-90. PubMed ID: 12789651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokines and chemokine receptors in glomerulonephritis and renal allograft rejection.
    Stasikowska O; Wagrowska-Danilewicz M
    Med Sci Monit; 2007 Feb; 13(2):RA31-6. PubMed ID: 17261994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokines in transplant rejection.
    Haskell CA; Ribeiro S; Horuk R
    Curr Opin Investig Drugs; 2002 Mar; 3(3):399-405. PubMed ID: 12054086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different islet protein expression profiles during spontaneous diabetes development vs. allograft rejection in BB-DP rats.
    Christensen UB; Larsen PM; Fey S; Karlsen AE; Pociot F; Nerup J; Sparre T
    Autoimmunity; 2006 Jun; 39(4):315-21. PubMed ID: 16891220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential role of CCR2 in islet and heart allograft rejection: tissue specificity of chemokine/chemokine receptor function in vivo.
    Abdi R; Means TK; Ito T; Smith RN; Najafian N; Jurewicz M; Tchipachvili V; Charo I; Auchincloss H; Sayegh MH; Luster AD
    J Immunol; 2004 Jan; 172(2):767-75. PubMed ID: 14707046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokine and toll-like receptor signaling in macrophage mediated islet xenograft rejection.
    Chandra AP; Ouyang L; Yi S; Wong JK; Ha H; Walters SN; Patel AT; Stokes R; Jardine M; Hawthorne WJ; O'Connell PJ
    Xenotransplantation; 2007 Jan; 14(1):48-59. PubMed ID: 17214704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of chemokine signaling pathways in pancreatic islet rejection during allo- and xenotransplantation.
    Sigrist S; Ebel N; Langlois A; Bosco D; Toso C; Kleiss C; Mandes K; Berney T; Pinget M; Belcourt A; Kessler L
    Transplant Proc; 2005 Oct; 37(8):3516-8. PubMed ID: 16298647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of CXCR3 and CCR5 in allograft rejection.
    Schnickel GT; Hsieh GR; Garcia C; Shefizadeh A; Fishbein MC; Ardehali A
    Transplant Proc; 2006 Dec; 38(10):3221-4. PubMed ID: 17175228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response.
    van Loosdregt J; van Oosterhout MF; Bruggink AH; van Wichen DF; van Kuik J; de Koning E; Baan CC; de Jonge N; Gmelig-Meyling FH; de Weger RA
    Circulation; 2006 Oct; 114(15):1599-607. PubMed ID: 17015796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokines and chronic heart allograft rejection.
    Smith RN; Ueno T; Ito T; Tanaka K; Shea SP; Abdi R
    Transplantation; 2007 Aug; 84(3):442-4. PubMed ID: 17700176
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunity to islet grafts transduced with adenovirus vectors does not inhibit long-term islet function.
    Cheng J; Sun J; Sung RS
    Transpl Immunol; 2009 May; 21(1):33-42. PubMed ID: 19224710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokines in transplantation: what can atypical receptors teach us about anti-inflammatory therapy?
    O'Boyle G; Ali S; Kirby JA
    Transplant Rev (Orlando); 2011 Oct; 25(4):136-44. PubMed ID: 21514134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coinhibitory T-cell signaling in islet allograft rejection and tolerance.
    Truong W; Hancock WW; Anderson CC; Merani S; Shapiro AM
    Cell Transplant; 2006; 15(2):105-19. PubMed ID: 16719045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine gene expression during allograft rejection: comparison of two quantitative PCR techniques.
    Carvalho-Gaspar M; Billing JS; Spriewald BM; Wood KJ
    J Immunol Methods; 2005 Jun; 301(1-2):41-52. PubMed ID: 16018884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From basic science to clinical practice: use of cytokines and chemokines as therapeutic targets in renal diseases.
    Romagnani P
    J Nephrol; 2005; 18(3):229-33. PubMed ID: 16013008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Islet expression of M3 uncovers a key role for chemokines in the development and recruitment of diabetogenic cells in NOD mice.
    Martin AP; Grisotto MG; Canasto-Chibuque C; Kunkel SL; Bromberg JS; Furtado GC; Lira SA
    Diabetes; 2008 Feb; 57(2):387-94. PubMed ID: 18003753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of donor dendritic cells and enhancement of dendritic cell efflux with CC-chemokine ligand 21: a novel strategy to prolong islet allograft survival.
    Fiorina P; Jurewicz M; Tanaka K; Behazin N; Augello A; Vergani A; von Andrian UH; Smith NR; Sayegh MH; Abdi R
    Diabetes; 2007 Apr; 56(4):912-20. PubMed ID: 17287465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical islet transplantation at the University of Alberta--the Edmonton experience.
    Truong W; Lakey JR; Ryan EA; Shapiro AM
    Clin Transpl; 2005; ():153-72. PubMed ID: 17424733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.